Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Strata Critical Medical (SRTA) Net Margin (2020 - 2025)

Strata Critical Medical (SRTA) has disclosed Net Margin for 6 consecutive years, with 5.16% as the latest value for Q4 2025.

  • Quarterly Net Margin rose 134.0% to 5.16% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 23.38% through Dec 2025, up 3081.0% year-over-year, with the annual reading at 31.15% for FY2025, 3874.0% up from the prior year.
  • Net Margin for Q4 2025 was 5.16% at Strata Critical Medical, down from 136.06% in the prior quarter.
  • The five-year high for Net Margin was 136.06% in Q3 2025, with the low at 71.49% in Q4 2023.
  • Average Net Margin over 5 years is 10.39%, with a median of 9.94% recorded in 2021.
  • The sharpest move saw Net Margin crashed -5983bps in 2021, then skyrocketed 12587bps in 2025.
  • Over 5 years, Net Margin stood at 3.14% in 2021, then crashed by -1389bps to 40.42% in 2022, then crashed by -77bps to 71.49% in 2023, then skyrocketed by 91bps to 6.49% in 2024, then grew by 21bps to 5.16% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 5.16%, 136.06%, and 5.29% for Q4 2025, Q3 2025, and Q2 2025 respectively.